OBJECTIVES: To analyse our institutional results in the setting of paediatric aortic valve (AV) repair. Primary end-points were overall survival, freedom from AV reoperation and freedom from AV replacement.
INTRODUCTION
Aortic valvulopathy 'at large' represents 4% of all primary diagnosis of congenital heart disease (CHD). Those include all forms of stenosis located at the subvalvar, valvar and supravalvar levels as well as aortic regurgitation (AR) [1] .
A large variety of syndromes or phenotypes share in common some form of dysfunction of the AV. For aortic valve regurgitation (AVR), the two commonest entities are leaflet prolapses associated with ventricular septal defect (VSD) (Pezzi-Laubri syndrome) and AVR following percutaneous balloon aortic valvuloplasty [2, 3] .
For the stenotic lesions, those can be secondary to dysmorphic uni-, bi-or tricuspid valves, but complex forms of multilevel left ventricular outflow tract obstruction can be encountered.
Finally, critical aortic stenosis (AS) of the neonate is an entity apart from other forms of paediatric valvulopathies, as for those patients the prognosis will mostly be dependent on parameters such as the size of the aortic annulus and of the mitral valve, and the presence of endocardial fibroelastosis, all surrogate markers of an optimal in utero LV development [4, 5] .
As there are many different diagnoses associated with AV dysfunction, the timing during infancy and childhood at which the aortic pathology will have to be addressed varies greatly [6] .
Except from the Ross procedure, AV replacement in the paediatric group suffers from major drawbacks such as the lack of growth and the requirement for chronic anticoagulation, both contributing to decrease in overall survival and freedom from reoperation [7, 8] .
From the early days on, AV repair has been part of the armamentarium of congenital heart surgeons, but most techniques failed the test of time, finally leading towards AV replacement [9, 10] .
Our group has acquired an in-depth knowledge of the pathophysiology of AR in adults and has been actively involved in developing techniques of AV repairs in the adult population. With the growing confidence, some of those have been applied to our paediatric patients [11] [12] [13] [14] .
In this study, our objectives were to assess the mid-and longterm results of AV repair in the paediatric patients, and whether this 'repair first' strategy could provide some benefit in the long term, such as delaying or obviating the need for pulmonary autograft replacement (the Ross procedure), the gold standard for AV replacement in children.
MATERIALS AND METHODS

Patient population and demographics
We extracted data from our institutional patient database of all patients under 18 years of age with the following inclusion criteria: any preserving surgical procedure performed on the AV or any part of the AV isolated or combined with any other procedure done for CHD. Between 1977 and 2015, out of 168 paediatric patients undergoing AV surgery in our institution, 66 patients underwent primary AV repair.
The enrolment pattern for AV repair, Ross procedures and AV replacement over those four decades is illustrated in Fig. 1 . Table 1 summarizes patients' characteristics.
The median age at surgery was 8.8 years (interquartile range, IQR [4.4-13.7] ). The age distribution was skewed: 1 neonate and 4 infants among the entire group (8%), 38 children (57.5%) and 23 adolescents (35%). Overall, children above 1 year of age represented 92% of our cohort. There was a male preponderance (ratio m/f: 1.4), and most of the children were symptomatic at the time of surgery (64% in NYHA class II or III).
Since there were only 5 patients less than 1 year old and 3 patients between 1 and 2 years old, we choose for subsequent analysis to group those 8 patients together and compared them with the two older groups.
Indication for AV repair was stenosis in 13 patients, stenosis and regurgitation in 17 patients, and regurgitation only in 36 patients.
For the group with AS, the peak/mean gradients at surgery were 75 ± 29 and 47 ± 12 mmHg. For the group with aortic disease, the peak/mean gradients were 51 ± 21 and 36 ± 14 mmHg.
On preoperative echocardiography, 55 patients showed AR. AR was mild (Grade 1) in 12 patients, moderate (Grade 2) in 9 and severe (Grade 3 or 4) in 34 patients. The mean left ventricular (LV) shortening fraction was 38%. For patients with regurgitation, the mean indexed LV end-diastolic diameter (LVEDDi) was 51 mm.
According to the functional classification of AR [14] , 5 patients had type Ib AR, 23 patients had type II AR ( prolapse) and 27 had type III AR (restrictive). More than 50% of those valves were morphologically tricuspid, followed by bicuspid (33%), unicuspid (9%) and quadricuspid (4.5%).
Of note, concordance between preoperative echocardiography and perioperative findings was poor in the group with unicuspid morphology. All 6 patients were described as having bicuspid valves with raphe. Table 2 provides detailed information of the techniques used for valve repair.
When deemed necessary (26/66 patients; 39%), subcommissural annuloplasty was performed at each commissure of the valve with polytetrafluoroethylene-reinforced braided sutures. The U-shaped suture was passed horizontally through the aortic wall from one side of the commissure to the other as initially described by Cabrol et al. [15] . The annuloplasty was performed at half of the interleaflet triangle height or lower to obtain greater plication.
All leaflet extensions, leaflet and commissural reconstructions were performed using 0.6% glutaraldehyde-fixed autologous pericardium.
For this study, we defined three groups with incremental procedures on the valve: Group 1 (n = 30) includes patients with commissurotomy and/or shaving of the leaflet(s), those with leaflet perforation closure, those with bicuspidization of a tricuspid valve and those who underwent some type of leaflet free-edge shortening ( plication or Goretex reinforcement); Group 2 (n = 31) includes those with more complex repairs (bicuspidization of unicuspid valve, leaflet and/or commissural reconstruction or extension); and Group 3 includes those having a valve-sparing procedures (±leaflet plication, ±external annuloplasty) (n = 5). Among those, there were 3 Marfan and 1 Loetz-Dietz patients.
End-points of this study were overall survival, freedom from AV reoperation, freedom from AV replacement and freedom from recurrent AS or AR.
Data collection and follow-up
Retrospective chart review was performed for in-hospital data retrieval; most information about preoperative, operative and postoperative variables was collected by reviewing a computerized patient database, hospital charts, operative notes and autopsy reports if appropriate. Clinical and echocardiographic follow-up was either available through outpatient records for those followed at our institution or by mail request of detailed information from referring paediatric cardiologists. Information on survival status and valve-related complications, including thromboembolism, haemorrhage, endocarditis, reoperation and cardiovascular symptoms, was obtained. Transthoracic echocardiography (TTE) was obtained on most patients before discharge (91%) and at regular intervals during follow-up. Follow-up data are partially missing for 8 international patients operated on in the most recent years.
The closing interval for the study was June 2015. Clinical followup was 92% complete with a median follow-up time of 50 months (IQR ). Echocardiographic follow-up was 89% complete at a median TTE follow-up of 40 months (IQR ).
The study protocol was approved by our Institutional Ethical Board.
Statistical analysis
Valve-related outcomes were defined as per published guidelines [16] . Continuous data are presented as mean ± standard deviation. The normality of distribution was checked with the Shapiro-Wilk test and data that did not have a normal distribution are presented as median with the IQR.
For time to event analysis, patients were censored at the last available specific time entry, whether overall survival, echo recurrence of valve disease, reoperation or valve replacement.
Failure time data on survival, reoperation, valve replacement and recurrent AR are presented using Kaplan-Meier survival curves. Pre-and intraoperative variables (Tables 1 and 2) were tested in univariable analysis for the end-points of AV repair failure (AI grade >2 and/or Ao stenosis >60 mmHg or AV reoperation), using the proportional hazard model (Cox regression).
RESULTS
Early mortality and morbidity
Perioperative information is provided in Table 2 . The median aortic cross-clamping (ACC) and CPB times were 77 (IQR [54-99]) and 108 (IQR [87-147]) minutes, respectively. Importantly, in 10 patients, reinitiation of CPB was necessary at the index procedure, all but one for residual moderate or severe AR.
The in-hospital mortality rate was 1.5% (1/66). A 13-month old patient with previous neonatal aortic coarctation repair and AV balloon valvuloplasty subsequently developed a severe valvar and supravalvular stenosis. He underwent a complex AV repair associated with a root enlargement. After weaning from CPB, he developed a refractory low cardiac output syndrome despite optimal LV outflow tract obstruction (LVOTO) relief. Major morbidity included 1 neurological event (choreoathetosis), 1 bacteraemia, 1 low cardiac output syndrome and 10 pericardial effusions (1 needed pericardiocentesis).
Late mortality, morbidity
During follow-up, 3 other patients died at 104, 140 and 179 months, respectively. All deaths were cardiac related and occurred in patients with recurrent moderate to severe AR.
For the entire cohort, 5-, 10-and 15-year overall survival rates were 100, 95 and 79%, respectively (Fig. 2) .
In terms of symptoms, at the time of the last follow-up (or death), 52 patients were in NYHA I (80%), 12 patients in NYHA II (18%) and 1 patient in NYHA III.
Echocardiographic follow-up
Hospital discharge TTE was available in 60 patients (91%) and showed no AR in 19 patients (31.7%), Grade 1 AR in 36 patients (60%) or Grade 2 AR in 5 patients (8.3%), respectively.
Among those operated for AS (n = 13), the peak/mean gradient at discharge was on average 40 ± 21/27 ± 12 mmHg, and 3 patients had a mean gradient greater than 20 mmHg.
Among those operated for aortic disease (n = 17), the peak/mean gradient at discharge was on average 26 ± 15/22 ± 12 mmHg, and 2 patients had a mean gradient greater than 20 mmHg.
Follow-up TTE was available in 59 patients (89%). Of those, 10 patients had no AR (15.1%), 27 patients had AR Grade 1 (46.5%), and 13 patients (22.4%) and 9 patients (15.5%) had AR Grade 2 and 3, respectively.
Among those operated for AS (n = 13), the peak/mean gradient at follow-up was on average 48 ± 27/32 ± 15 mmHg, and 6 patients had a mean gradient greater than 20 mmHg.
Among those operated for aortic disease (n = 17), the peak/mean gradient at follow-up was on average 49 ± 28/29 ± 16 mmHg, and 5 patients had a mean gradient greater than 20 mmHg.
The mean LV shortening fraction was 37% [30-42%] and the mean LVESD was 32 mm [29-42 mm].
Overall, 7 patients (23%) had significant recurrent AS. Among those operated for AS (n = 13), 4 patients developed significant stenosis (31%), and among those operated for aortic disease (n = 17), 3 patients developed significant stenosis (17%).
From the 5 patients with AR Grade 2 at discharge, there were two progressions to AR Grade 3 and one recurrence of stenosis which required re-repair. Overall, 22 patients (33%) had regurgitation ≥Grade 2 and 9 patients severe (Grade 3 or more) AR (13.6%) at their last follow-up.
As illustrated in Fig. 3 , freedom from AS ( peak Gdt >60 mmHg) and/or AR >Grade 2 at 5, 10 and 15 years was 88.7, 75.9 and 65%, respectively.
Freedom from valve-related reintervention
There were 18 surgical reinterventions in this cohort, with 16 valve-related reoperations (in 11 patients). There was no hospital mortality in those patients at reoperation.
The median time to first AV reintervention was 67 months (IQR [29-110]). At first AV reintervention, indication for surgery was recurrence of severe AR in 4, severe AS in 3 and mixed disease in 4 patients. Three of the 4 patients with AR could be re-repaired, together with 1 patient with recurrent mixed disease.
Six of the 7 patients with recurrent severe stenosis or mixed disease had a valve replacement. Overall four Ross, one RossKonno and two mechanical valves were performed as the first AV reintervention.
Five patients underwent a second AV-related procedure: 2 patients had both mitral and aortic mechanical valve replacement, 1 autograft (Ross) failed and was replaced by a mechanical valve, and 2 more patients underwent a Ross procedure. The median time to second AV reintervention was 123 months (IQR [48-189 months] ).
The freedom rates from valve-related reintervention at 5, 10 and 15 years were 90, 72 and 72%, respectively (Fig. 4A) . On analysis according to the complexity of repair, there was no significant difference among the three groups. Interestingly, all valve-sparing procedures were free from reoperation as illustrated in Fig. 4B .
The use of patch (either for cusp extension or for commissural reconstruction, n = 19) for the repair did not impair its longevity (Fig. 4C) , nor the initial diagnosis of AR-VSD (Pezzi-Laubry) (not shown).
Freedom from valve replacement
At completion of follow-up, 9 patients had their native valve replaced [6 had a Ross (± Konno) procedure and 3 had mechanical prostheses]. The median time to AV replacement was 94.7 months (IQR [29-220]).
Freedom rates from valve replacement at 5, 10 and 15 years were 90, 81.1 and 74.8%, respectively (Fig. 5A) .
Univariable analysis of predictors of valve repair failure leading to valve replacement identified valve phenotype and younger age at surgery (<2 years old versus all other groups) as the only significant risk factors. Surgical era, valve pathophysiology, prior AV balloon valvuloplasty, complexity of the repair and use of patches were not found to be predictors of failure. Interestingly, having moderate AR (Grade 2) on discharge or a mean transvalvular gradient >20 mmHg was not predictive of late valve failure (Table 3) .
Freedom from major adverse event
In this cohort of patients, there were no recorded episode of thromboembolism, haemorrhage or endocarditis, and no patient required implantation of pacemaker (PCMK).
DISCUSSION
The results of this study support the current surgical trend to consider AV repair as the first choice for paediatric patients with AS and/or regurgitation in whom structural AV deterioration has not extended too far.
In-hospital mortality is generally low [17, 18] . In our experience, there was only one perioperative death. One explanation could be that our population consisted mostly of children beyond 1 year of age (mean age: 8 years old), which is similar to both the Melbourne [17] and the Houston experience [18] . Our patient's characteristics were similar to these series, for the proportion of AS or AR (around 50% each), the percentage of previous balloon aortic valvuloplasty (12-30%) and the phenotypes of the repaired valves (mostly bi-and tricuspid).
Our cohort of patients had excellent 5-, 10-and even 15-year rates of freedom from AV replacement, with rates of replacement that compare favourably to other contemporary studies. Indeed, Bacha et al. [19] reported 5-and 10-year rates of freedom from AV [18] reported a 5-year rate of freedom from AV reintervention of 75% (excluding the truncal repair group); and d'Udekem et al. [17] recently reported 90 and 50% freedom from AV replacement at 5 and 10 years for their entire cohort of repair, which included about 100 paediatric patients older than 1 year old.
The stability of the repair in our study was satisfactory with 90, 72 and 72% freedom from AV reintervention at 5-, 10-and 15 years, respectively. One of the reasons for this improved longevity might reside in the fact that in our surgical technique, we have rarely used leaflet extension as a tool to obtain a competent AV. Only 10 patients (15%) underwent leaflet extension in our 38 years of experience. In comparison, leaflet extension was used in 30% of the patients in the Melbourne experience [17] and in 80% of the Boston experience [19] . Indeed, the subgroup of patients in Melbourne without the leaflet extension technique had a much higher freedom from AV reintervention. Also supporting this hypothesis, Wilder et al. [20] had a nearly 50% valve-related reoperation rate in their series of older children when they used leaflet extension, with a mean time to re-repair/replacement of 4.4 years.
Univariable analysis of predictors for later AV replacement identified only two variables that negatively impacted the repairs: younger age at repair (<2 years old) and a unicuspid phenotype. Younger age at repair was also found as a risk factor by d'Udekem et al. [17] (freedom from aortic reintervention) and Khan et al. [18] (freedom from AV replacement), while valve phenotype was not found to be predictive in the d'Udekem study. The low number of patients with a unicuspid phenotype (5% in Melbourne, 9% in our series) limits the interpretation of those data.
Interestingly, in our experience whether the valve was stenotic or regurgitant, prior AV balloon valvuloplasty, complexity of the repair and use of patches were not predictors of failure. Even moderate AR (Grade 2) on discharge or mean transvalvular gradient >20 mmHg was not predictive of late valve failure.
Finally, the follow-up of those repairs was remarkable for the absence of any valve-related adverse event (thromboembolism, haemorrhage, endocarditis, PCMK requirement), underlining of the low morbidity on the long run of such procedures and the freedom from medical treatment, thereby confirming its ' first choice strategy' as it has been suggested previously. One could question the rationale for repair in the oldest age group (>12 years old) recognizing the excellent early and midterm results of contemporary mechanical valves in adolescents [18] . Khan et al. reported no hospital mortality and rate of freedom from death of reintervention of 79% at 5 years, in their subgroup of 62 patients over 14 years old.
However, a recent meta-analysis of long-term studies comparing non-Ross AVR versus Ross AVR [21] underscored that mechanical valve replacement in children still conveys an increased risk of late mortality as well as valve-related complications.
In summary, our current approach in congenital AV pathology is conservative with the exception of severe lesions at both the subvalvular and valvular levels. This is well illustrated by the shift in the number of Ross and repairs over the last two decades (Fig. 1) .
For unicuspid morphology, we favour bicuspidization by complete commissural reconstruction. The same principle of repair is applied to other morphologies previously treated with balloon dilatation and presenting with severely diseased commissural areas. Cusp extension is used only when, after careful analysis of all components of the root, the level of coaptation is deemed not to reach the mid-height of the respective sinus. Indeed, insufficient coaptation length has been shown to be predictive of repair failure [22, 23] .
Study limitations
It is a single retrospective study with all its potential biases. As usual for uncommon congenital pathologies, our study includes a small number of patients, covering a period of 30 years, and a wide spectrum of disease and of surgical techniques. Therefore, the study tended to be descriptive. However, our group has been developing a rather standardized surgical approach to aortic root pathology over the last 20 years [11] [12] [13] [14] , which tends to make our approach to patient's pathology homogeneous for the techniques used. Nevertheless, the small samples size should also prompt us to be cautious about interpretation of negative results.
CONCLUSION
In our experience, AV repair in the paediatric population provides excellent results in terms of both overall survival and valve-related reoperation. It obviates the need for chronic anticoagulation and in most cases delays the time at which more complex surgery (as Ross procedure) must be undertaken.
